评估试验方案报告质量的重复横断面研究:ASPIRE研究的设计与原理
ASPIRE研究基于瑞士、英国、德国和加拿大伦理委员会2012年批准的450份及2016年批准的402份随机对照试验方案,评估SPIRIT指南发布前后方案对SPIRIT清单的依从性,分析非依从相关特征及国家间差异,并关联方案依从性与试验注册、完成及发表。
要点
- SPIRIT指南2013年发布,其对方案完整性的影响及与试验成功的关系尚不确定。
- ASPIRE研究纳入2012年450份和2016年402份伦理委员会批准的试验方案。
- 将用多变量回归分析依从性的时间变化、国家差异及与注册、完成、发表的关系。
核心结论
- ASPIRE研究将提供SPIRIT指南对试验方案报告质量影响的证据,并探索方案依从性与试验注册、完成及发表的关系。
研究设计与样本
- 国际队列研究,基于瑞士、英国、德国和加拿大伦理委员会2012年批准的450份和2016年批准的402份随机对照试验方案。
- 提取所有纳入方案的试验特征和SPIRIT依从性数据,使用多变量回归模型分析时间变化、国家差异及与注册、完成、发表结果的关联。
- 计划开展子研究,考察试验注册、提前终止、未发表、患者报告结局使用、非 regulated 干预方案依从性、亚组分析计划及常规收集数据使用。
关键数值与推荐
- SPIRIT(Standard Protocol Items: Recommendations for Interventional Trials)指南于2013年发布,旨在提高临床试验方案的准确性和完整性。
临床怎么用
- 研究结果可帮助伦理委员会、资助机构等利益相关者评估SPIRIT指南对方案报告质量的影响。
- 可揭示方案依从性与试验注册、完成及发表之间的关联,为改进方案报告提供依据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Clearly structured and comprehensive protocols are an essential component to ensure safety of participants, data validity, successful conduct, and credibility of results of randomized clinical trials (RCTs). Funding agencies, research ethics committees (RECs), regulatory agencies, medical journals, systematic reviewers, and other stakeholders rely on protocols to appraise the conduct and reporting of RCTs. In response to evidence of poor protocol quality, the Standard Protocol Items: Recommendations for Interventional Trials (SPIRIT) guideline was published in 2013 to improve the accuracy and completeness of clinical trial protocols. The impact of these recommendations on protocol completeness and associations between protocol completeness and successful RCT conduct and publication remain uncertain. OBJECTIVES AND METHODS: Aims of the Adherence to SPIrit REcommendations (ASPIRE) study are to investigate adherence to SPIRIT checklist items of RCT protocols approved by RECs in the UK, Switzerland, Germany, and Canada before (2012) and after (2016) the publication of the SPIRIT guidelines; determine protocol features associated with non-adherence to SPIRIT checklist items; and assess potential differences in adherence across countries. We assembled an international cohort of RCTs based on 450 protocols approved in 2012 and 402 protocols approved in 2016 by RECs in Switzerland, the UK, Germany, and Canada. We will extract data on RCT characteristics and adherence to SPIRIT for all included protocols. We will use multivariable regression models to investigate temporal changes in SPIRIT adherence, differences across countries, and associations between SPIRIT adherence of protocols with RCT registration, completion, and publication of results. We plan substudies to examine the registration, premature discontinuation, and non-publication of RCTs; the use of patient-reported outcomes in RCT protocols; SPIRIT adherence of RCT protocols with non-regulated interventions; the planning of RCT subgroup analyses; and the use of routinely collected data for RCTs. DISCUSSION: The ASPIRE study and associated substudies will provide important information on the impact of measures to improve the reporting of RCT protocols and on multiple aspects of RCT design, trial registration, premature discontinuation, and non-publication of RCTs observing potential changes over time.
引用
- Gryaznov D, Odutayo A, von Niederhäusern B, et al. Rationale and design of repeated cross-sectional studies to evaluate the reporting quality of trial protocols: the Adherence to SPIrit REcommendations (ASPIRE) study and associated projects. Trials. 2020. PMID: 33115541. doi:10.1186/s13063-020-04808-y
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。